Lupin Gets FDA Tentative Approval for Revefenacin Inhalation Solution for COPD#India#Mumbai#Lupin_Limited#Yupelri_COPD#Revefenacin_Inhalation
Lupin Gets FDA Tentative Approval for Revefenacin Inhalation Solution for COPD
Lupin Limited has received tentative approval from the U.S. FDA for their Revefenacin Inhalation Solution, targeting COPD patients. A significant step for the pharmaceutical giant.
third-news.com
May 18, 2026 at 6:09 PM
Lupin Gets FDA Tentative Approval for Revefenacin Inhalation Solution for COPD#India#Mumbai#Lupin_Limited#Yupelri_COPD#Revefenacin_Inhalation